Literature DB >> 22290754

Production of identical retention times and mass spectra for {delta}9-tetrahydrocannabinol and cannabidiol following derivatization with trifluoracetic anhydride with 1,1,1,3,3,3-hexafluoroisopropanol*.

Rebecca Andrews1, Sue Paterson.   

Abstract

The use of perfluorinated anhydrides coupled with perfluoroalcohols for the derivatization of cannabinoids has been well documented. Derivatization is used in the detection of cannabinoids using gas chromatography-mass spectrometry (GC-MS) with both electron impact ionization (EI) and negative chemical ionization (NCI). During method development for the analysis of cannabinoids in biological samples using GC-MS in EI and NCI mode, it was observed that when Δ(9)-tetrahydrocannabinol (THC) and cannabidiol (CBD) were derivatized with trifluoroacetic anhydride (TFAA), the resultant derivatives produced the same retention times and mass spectra. This was not observed with the trimethylsilyl (TMS) derivatives of THC and CBD. This complication is due to the conversion of CBD to THC under acidic conditions. The work here highlights the unsuitability of the derivatizing reagent TFAA for the detection of THC and CBD. For the analysis of case samples, even if only THC is of interest, the presence of CBD cannot be excluded, and other derivatization techniques should be used.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22290754     DOI: 10.1093/jat/bkr017

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  3 in total

1.  Ultra-high performance liquid chromatography tandem mass-spectrometry for simple and simultaneous quantification of cannabinoids.

Authors:  Rohitash Jamwal; Ariel R Topletz; Bharat Ramratnam; Fatemeh Akhlaghi
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2017-02-06       Impact factor: 3.205

2.  Pharmacokinetic Profile of ∆9-Tetrahydrocannabinol, Cannabidiol and Metabolites in Blood following Vaporization and Oral Ingestion of Cannabidiol Products.

Authors:  Cecilia L Bergeria; Tory R Spindle; Edward J Cone; Dennis Sholler; Elia Goffi; John M Mitchell; Ruth E Winecker; George E Bigelow; Ronald Flegel; Ryan Vandrey
Journal:  J Anal Toxicol       Date:  2022-07-14       Impact factor: 3.220

3.  In vitro stability of free and glucuronidated cannabinoids in blood and plasma following controlled smoked cannabis.

Authors:  Karl B Scheidweiler; David M Schwope; Erin L Karschner; Nathalie A Desrosiers; David A Gorelick; Marilyn A Huestis
Journal:  Clin Chem       Date:  2013-03-21       Impact factor: 8.327

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.